Irish firm Covidien has announced it intends to spin off its Hazelwood, Mo.-based pharmaceutical unit Mallinckrodt on June 28. The spinoff company will be called Mallinckrodt Pharmaceuticals.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||